Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 168

Similar articles for PubMed (Select 21743489)

1.

NAC1 modulates sensitivity of ovarian cancer cells to cisplatin by altering the HMGB1-mediated autophagic response.

Zhang Y, Cheng Y, Ren X, Zhang L, Yap KL, Wu H, Patel R, Liu D, Qin ZH, Shih IM, Yang JM.

Oncogene. 2012 Feb 23;31(8):1055-64. doi: 10.1038/onc.2011.290. Epub 2011 Jul 11.

2.

NAC1 and HMGB1 enter a partnership for manipulating autophagy.

Zhang Y, Yang JW, Ren X, Yang JM.

Autophagy. 2011 Dec;7(12):1557-8.

3.

Induction of autophagy contributes to cisplatin resistance in human ovarian cancer cells.

Bao L, Jaramillo MC, Zhang Z, Zheng Y, Yao M, Zhang DD, Yi X.

Mol Med Rep. 2015 Jan;11(1):91-8. doi: 10.3892/mmr.2014.2671. Epub 2014 Oct 16.

4.

Induction of autophagy counteracts the anticancer effect of cisplatin in human esophageal cancer cells with acquired drug resistance.

Yu L, Gu C, Zhong D, Shi L, Kong Y, Zhou Z, Liu S.

Cancer Lett. 2014 Dec 1;355(1):34-45. doi: 10.1016/j.canlet.2014.09.020. Epub 2014 Sep 16.

PMID:
25236911
5.

Erlotinib-induced autophagy in epidermal growth factor receptor mutated non-small cell lung cancer.

Li YY, Lam SK, Mak JC, Zheng CY, Ho JC.

Lung Cancer. 2013 Sep;81(3):354-61. doi: 10.1016/j.lungcan.2013.05.012. Epub 2013 Jun 13.

PMID:
23769318
6.

Dysfunction of nucleus accumbens-1 activates cellular senescence and inhibits tumor cell proliferation and oncogenesis.

Zhang Y, Cheng Y, Ren X, Hori T, Huber-Keener KJ, Zhang L, Yap KL, Liu D, Shantz L, Qin ZH, Zhang S, Wang J, Wang HG, Shih IeM, Yang JM.

Cancer Res. 2012 Aug 15;72(16):4262-75. doi: 10.1158/0008-5472.CAN-12-0139. Epub 2012 Jun 4.

7.

Chloroquine blocks the autophagic process in cisplatin-resistant osteosarcoma cells by regulating the expression of p62/SQSTM1.

Shen C, Wang W, Tao L, Liu B, Yang Z, Tao H.

Int J Mol Med. 2013 Aug;32(2):448-56. doi: 10.3892/ijmm.2013.1399. Epub 2013 May 30.

PMID:
23722646
8.

NAC-1, a potential stem cell pluripotency factor, contributes to paclitaxel resistance in ovarian cancer through inactivating Gadd45 pathway.

Jinawath N, Vasoontara C, Yap KL, Thiaville MM, Nakayama K, Wang TL, Shih IM.

Oncogene. 2009 May 7;28(18):1941-8. doi: 10.1038/onc.2009.37. Epub 2009 Mar 23.

9.

Nrf2 induces cisplatin resistance through activation of autophagy in ovarian carcinoma.

Bao LJ, Jaramillo MC, Zhang ZB, Zheng YX, Yao M, Zhang DD, Yi XF.

Int J Clin Exp Pathol. 2014 Mar 15;7(4):1502-13. eCollection 2014.

10.

Up-regulated autophagy by endogenous high mobility group box-1 promotes chemoresistance in leukemia cells.

Yang L, Yu Y, Kang R, Yang M, Xie M, Wang Z, Tang D, Zhao M, Liu L, Zhang H, Cao L.

Leuk Lymphoma. 2012 Feb;53(2):315-22. doi: 10.3109/10428194.2011.616962. Epub 2011 Nov 15.

PMID:
21864037
11.

Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma.

Shimizu S, Takehara T, Hikita H, Kodama T, Tsunematsu H, Miyagi T, Hosui A, Ishida H, Tatsumi T, Kanto T, Hiramatsu N, Fujita N, Yoshimori T, Hayashi N.

Int J Cancer. 2012 Aug 1;131(3):548-57. doi: 10.1002/ijc.26374. Epub 2011 Sep 12.

PMID:
21858812
12.

Caveolin-1 functions as a key regulator of 17β-estradiol-mediated autophagy and apoptosis in BT474 breast cancer cells.

Wang R, He W, Li Z, Chang W, Xin Y, Huang T.

Int J Mol Med. 2014 Sep;34(3):822-7. doi: 10.3892/ijmm.2014.1836. Epub 2014 Jul 7.

PMID:
25017566
13.

Nac1 interacts with the POZ-domain transcription factor, Miz1.

Stead MA, Wright SC.

Biosci Rep. 2014 Jun 5;34(3). pii: e00110. doi: 10.1042/BSR20140049.

14.

Biological role and prognostic significance of NAC1 in ovarian cancer.

Nakayama K, Rahman MT, Rahman M, Yeasmin S, Ishikawa M, Katagiri A, Iida K, Nakayama N, Miyazaki K.

Gynecol Oncol. 2010 Dec;119(3):469-78. doi: 10.1016/j.ygyno.2010.08.031. Epub 2010 Sep 24.

PMID:
20869761
15.

Suppression of chloride channel 3 expression facilitates sensitivity of human glioma U251 cells to cisplatin through concomitant inhibition of Akt and autophagy.

Su J, Xu Y, Zhou L, Yu HM, Kang JS, Liu N, Quan CS, Sun LK.

Anat Rec (Hoboken). 2013 Apr;296(4):595-603. doi: 10.1002/ar.22665. Epub 2013 Feb 13.

16.

MiRNA-30a-mediated autophagy inhibition sensitizes renal cell carcinoma cells to sorafenib.

Zheng B, Zhu H, Gu D, Pan X, Qian L, Xue B, Yang D, Zhou J, Shan Y.

Biochem Biophys Res Commun. 2015 Apr 3;459(2):234-9. doi: 10.1016/j.bbrc.2015.02.084. Epub 2015 Feb 21.

PMID:
25712526
17.

Differential contributory roles of nucleotide excision and homologous recombination repair for enhancing cisplatin sensitivity in human ovarian cancer cells.

Wang QE, Milum K, Han C, Huang YW, Wani G, Thomale J, Wani AA.

Mol Cancer. 2011 Mar 8;10:24. doi: 10.1186/1476-4598-10-24.

18.

p62/SQSTM1 involved in cisplatin resistance in human ovarian cancer cells by clearing ubiquitinated proteins.

Yu H, Su J, Xu Y, Kang J, Li H, Zhang L, Yi H, Xiang X, Liu F, Sun L.

Eur J Cancer. 2011 Jul;47(10):1585-94. doi: 10.1016/j.ejca.2011.01.019. Epub 2011 Mar 1.

PMID:
21371883
19.

Silencing expression of UO-44 (CUZD1) using small interfering RNA sensitizes human ovarian cancer cells to cisplatin in vitro.

Leong CT, Ong CK, Tay SK, Huynh H.

Oncogene. 2007 Feb 8;26(6):870-80. Epub 2006 Jul 24.

PMID:
16862170
20.

Inhibition of Beclin 1 expression enhances cisplatin-induced apoptosis through a mitochondrial-dependent pathway in human ovarian cancer SKOV3/DDP cells.

Sun Y, Liu JH, Jin L, Sui YX, Lai L, Yang Y.

Oncol Res. 2014;21(5):261-9. doi: 10.3727/096504014X13946388748992.

PMID:
24854102
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk